Skip to main content
Figure 1 | Breast Cancer Research

Figure 1

From: Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Figure 1

Proposed strategy for application of pathology likelihood ratios in multifactorial likelihood analysis of BRCA1 or BRCA2 rare sequence variants. Cases carrying a variant of uncertain clinical significance, and with information on relevant pathology variables, are first assessed to determine that breast tumor pathology information was not a criterion used to trigger gene testing. ER, estrogen-receptor breast tumor status; PR, progesterone-receptor breast tumor status; HER2, HER2 breast tumor status; TN, triple-negative breast tumor status; Not TN, breast tumor status not triple-negative, after measurement of ER, PR, and HER2 status; ER-neg, ER-negative status; ER-pos, ER-positive status; G, grade; <50, breast cancer diagnosis at younger than 50 years for tumor with relevant pathology data; ≥50, breast cancer diagnosis at 50 to 70 years for tumor with relevant pathology data.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us